CN116549534B - Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions - Google Patents

Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions Download PDF

Info

Publication number
CN116549534B
CN116549534B CN202310713063.0A CN202310713063A CN116549534B CN 116549534 B CN116549534 B CN 116549534B CN 202310713063 A CN202310713063 A CN 202310713063A CN 116549534 B CN116549534 B CN 116549534B
Authority
CN
China
Prior art keywords
chicks
intestinal
mannooligosaccharide
growth
egg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202310713063.0A
Other languages
Chinese (zh)
Other versions
CN116549534A (en
Inventor
张为民
卿素珠
金硕
张雯
崔生玲
曹雅丽
杨奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest A&F University
Original Assignee
Northwest A&F University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest A&F University filed Critical Northwest A&F University
Priority to CN202310713063.0A priority Critical patent/CN116549534B/en
Publication of CN116549534A publication Critical patent/CN116549534A/en
Application granted granted Critical
Publication of CN116549534B publication Critical patent/CN116549534B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a pharmaceutical composition for promoting the growth of egg chicks and regulating intestinal functions, which consists of 1 g-2 g/kg of medlar and 0.4g/kg of mannooligosaccharide. The composition selects the optimal combination proportion according to physiological characteristics of different growth stages of the egg chicks, promotes the growth of the chicks, and improves intestinal digestion function and mucous membrane barrier function of the chicks. In vivo experiments show that: the combination of the two can enhance the growth performance of the egg chicks, enhance the digestion function of the chicks by enhancing the intestinal digestive enzyme activity, enhance the villus height and the villus cryptoratio of the small intestine, enhance the intestinal barrier function by up-regulating the relative expression quantity of intestinal tissue tight junction protein ZO-1, mucin MUC2 and atresia Occludin mRNA, and regulate the intestinal health state by reducing the pH of the cecum and increasing the number of lactobacillus in the cecum content.

Description

Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions
Technical Field
The invention relates to the technical field of Chinese herbal medicines and the technical field of poultry anti-pathogen cultivation, in particular to a pharmaceutical composition for promoting the growth of egg chickens and regulating intestinal functions.
Background
Due to excessive and excessive use of antibiotics, bacterial drug resistance is generated, the clinical treatment effect of veterinary antibiotics is reduced, the dosage of antibiotics is forced to be increased in the breeding industry, the residual risk of veterinary antibacterial drugs is increased, and the quality safety of livestock and poultry products is threatened.
The wolfberry fruits are rich in rich alkaloid, polysaccharide, flavonoid, fenic acid and other components, have the effects of resisting inflammation, regulating immunity, promoting growth, enhancing intestinal barrier and the like, and according to statistics, the annual planting area of the wolfberry fruits in Ningxia county exceeds 20 mu, the annual yield of dried wolfberry fruits exceeds 40000 tons, and the leftovers (mainly inferior fruits: too small fruits, broken fruits and pomace) generated in the wolfberry processing process reach over 2000 tons.
The mannooligosaccharide has been widely studied in human and animal health care, and has the effects of promoting growth, improving immunity and regulating the environment in intestinal tract, and has the advantages of less drug resistance and less drug residue.
However, the effect of single use of traditional Chinese medicine or mannooligosaccharide may have a certain limitation, so that a high-efficiency combination scheme is sought, and therefore, the screening of effective medicines in traditional Chinese herbal medicines and the combination of mannooligosaccharide are used for replacing growth-promoting antibiotics, thereby completely meeting the development requirements of healthy cultivation in modern society.
Disclosure of Invention
Aiming at the problems in the prior art, the invention aims to provide a pharmaceutical composition for promoting the growth of the egg chicks and regulating the intestinal functions, and the pharmaceutical composition combines medlar fruit powder and mannooligosaccharide, so that the growth performance of the egg chicks is effectively improved, and the intestinal functions are enhanced.
The technical scheme adopted for achieving the aim of the invention is as follows: a pharmaceutical composition for promoting the growth of egg chicks and regulating intestinal functions comprises 1 g-2 g/kg of medlar and 0.4g/kg of mannooligosaccharide.
The optimal proportion of the pharmaceutical composition for promoting the growth of the egg chicks and regulating the intestinal functions is composed of 2g/kg of medlar and 0.4g/kg of mannooligosaccharide.
The invention relates to a pharmaceutical composition for promoting the growth of egg chickens and regulating intestinal functions, wherein medlar is medlar powder.
The invention relates to a pharmaceutical composition for promoting the growth of egg chickens and regulating intestinal functions, wherein the egg chickens are 7-49 days old.
It is still another object of the present invention to provide a pharmaceutical composition for promoting the growth of egg chickens and regulating intestinal function for the treatment of intestinal digestive function and intestinal mucosal barrier function.
The specific application of the pharmaceutical composition for promoting the growth of the egg chicks and regulating the intestinal functions in different growth stages of the egg chicks is as follows:
s1, in the daily ration of the chicks 7, starting to use 2g/kg, 1g/kg and 0.5g/kg of medlar residual fruit powder and above doses respectively with 0.4g/kg of mannooligosaccharide and 0.4g/kg of mannooligosaccharide in the daily ration, and calculating the average daily gain and the feed-weight ratio of the chicks per week.
S2, under the same treatment as the S1, determining the duodenal digestive enzyme activity of the chicks at 28 days old and 49 days old respectively, and determining the villus height, the crypt depth and the villus-crypt ratio of the small intestine, thereby determining the relative expression quantity of the protein mRNA related to the mucous membrane barrier of the small intestine.
According to the application method, the chicks are divided into different growth stages according to daily ration, and proper combination proportion is selected according to physiological characteristics of each growth stage and the existing research results, so that the medication science and safety are improved, and meanwhile, the production investment is reduced.
Drawings
FIG. 1 is a graph showing the effect of adding 2g/kg of wolfberry to the diet on the activity of the duodenal digestive enzyme of a chick;
FIG. 2 is a graph showing the effect of the combination of 2g/kg of wolfberry and 0.4g/kg of mannooligosaccharide on the activity of the duodenal digestive enzyme of a chick;
FIG. 3 is a graph showing the effect of adding 1g/kg of wolfberry and 0.4g/kg of mannooligosaccharide to the chick duodenal digestive enzyme activity;
FIG. 4 is a graph showing the effect of high doses of Lycium barbarum and mannooligosaccharide on the relative expression levels of chicken intestine Occlude;
FIG. 5 is a graph showing the effect of high doses of Lycium barbarum and mannooligosaccharide on the relative expression level of ZO-1mRNA in the small intestine of chickens;
FIG. 6 is a graph showing the effect of the dose of Lycium barbarum and mannooligosaccharide on the relative expression level of chicken intestine Occlude;
FIG. 7 is a graph showing the effect of the dose of Lycium barbarum and mannooligosaccharide on the relative expression level of ZO-1mRNA in the small intestine of chicks;
FIG. 8 is a graph showing the effect of low dose matrimony vine and mannooligosaccharide on the relative expression level of chick small intestine Occludin;
FIG. 9 is a graph showing the effect of low dose of Lycium barbarum and mannooligosaccharide on the relative expression level of ZO-1mRNA in the small intestine of chicks;
FIG. 10 is a graph showing the effect of high doses of Lycium barbarum and mannooligosaccharide on the relative expression level of MUC2 mRNA in the intestinal tract of chickens;
FIG. 11 is a graph showing the effect of dose of matrimony vine and mannooligosaccharide on the relative expression level of MUC2 mRNA in the intestinal tract of chickens;
FIG. 12 is a graph showing the effect of low doses of matrimony vine and mannooligosaccharide on the relative expression level of MUC2 mRNA in the intestinal tract of chickens;
FIG. 13 is a graph showing the effect of matrimony vine and mannooligosaccharide on the number of E.coli in chickens;
FIG. 14 is a graph showing the effect of matrimony vine and mannooligosaccharide on the number of Lactobacillus cecum in chickens.
Detailed Description
Hereinafter, only certain exemplary embodiments are briefly described. As will be recognized by those skilled in the pertinent art, the described embodiments may be modified in numerous different ways without departing from the spirit or scope of the embodiments of the present invention, which should also be considered as being within the scope of the present invention. Accordingly, the description of the embodiments is to be regarded as illustrative in nature and not as restrictive.
Example 1
A pharmaceutical composition for promoting growth of egg chicken and regulating intestinal function comprises 1g/kg fructus Lycii and 0.4g/kg mannooligosaccharide.
Example 2
A pharmaceutical composition for promoting growth of egg chicken and regulating intestinal function comprises fructus Lycii 2g/kg and mannooligosaccharide 0.4 g/kg.
Test example 1: testing of growth performance of egg chicks
Chicks are randomly divided into 8 groups, 3 level repeats are set, each repeat is carried out on 12 chicks, 2g/kg, 1g/kg, 0.5g/kg of medlar residue fruit powder and above in daily ration are respectively combined with 0.4g/kg of mannooligosaccharide and 0.4g/kg of mannooligosaccharide in daily ration 7 daily ration, and specific groups are shown in table 1. The test period was 42 days. In the raising process, the raising conditions of each group of chicks are consistent, the chicks can eat and drink water freely, and the chicken house can be subjected to normal disinfection and immunization procedures.
TABLE 1 chick grouping
Grouping Treatment of
Blank group (CON) Basic daily ration for feeding
High-dose group of defective medlar fruit (LBH) Basic ration +2g/kg of medlar residual fruit
Chinese wolfberry incomplete fruit dose group (LBM) Basic ration +1g/kg of medlar residual fruit
Chinese wolfberry fruit low dose group (LBL) Basic ration plus 0.5g/kg of medlar residual fruit
High dose combination (LBH+ACT) Basic ration, 2g/kg of medlar residual fruit and 0.4g/kg of mannooligosaccharide
Medium dose combination (LBM+ACT) Basic ration, 1g/kg of medlar residual fruit and 0.4g/kg of mannooligosaccharide
Low dose combination (LBL+ACT) Basic ration, 0.5g/kg of medlar residual fruit, 0.4g/kg of mannooligosaccharide
Mannooligosaccharide group (ACT) Basic ration plus 0.4g/kg mannooligosaccharide
Note that: the control group, the high, medium, low dose combination group, and the mannooligosaccharide group are denoted by CON, LBH, LBM, LNL, LBH +act, lbm+act, lbl+act, and ACT, respectively, and are the same in the following tables and figures.
The weekly feed consumption of the test chicks was recorded during the test, the weight was weighed on an empty stomach before feeding every morning and recorded, and the Average Daily Gain (ADG) and the feed-to-weight ratio (F/G) of the chicks per week were calculated.
As shown in Table 2, when 2g/kg of fructus Lycii residue fruit powder and 0.4g/kg of mannooligosaccharide are mixed for feeding, average daily weight gain of chicks at 3, 4, 6 and 7 weeks can be improved, and the feed-weight ratio of 6 and 7 weeks can be reduced. Showing that the chick growth performance can be improved when 2g/kg of medlar residual fruit powder and 0.4g/kg of mannooligosaccharide are mixed for feeding.
TABLE 2 Effect of Lycium barbarum and mannooligosaccharide on chick growth Performance
Note that: the same lower case letters of the shoulder marks are compared with each other, two upper case letters indicate that the difference is extremely remarkable (P < 0.01), and one upper case letter indicates that the difference is remarkable (P < 0.05).
Test example 2: intestinal digestion function determination test for egg chicks
The above test example 1 group feeding scheme was carried out by dissecting chicks at 28 and 49 days of age, respectively, taking the duodenal contents, carrying out trypsin, lipase and amylase activity detection by using an enzyme activity test kit, taking the duodenum, jejunum and ileum sections, washing cleanly, placing in 4% paraformaldehyde, fully fixing to prepare paraffin sections, then HE staining, measuring the villus height and crypt depth of the small intestine, and calculating the villus-crypt ratio.
Fig. 1 to 3 are graphs showing the effect of various proportions of wolfberry and mannooligosaccharides on the activity of the chicken duodenal digestive enzyme. And (3) injection: * Indicating significant differences (P < 0.05), indicating very significant differences (P < 0.01).
As shown in figures 1-3, 2g/kg of medlar residual fruit powder and 2g/kg and 1g/kg of medlar residual fruit powder are added into daily ration, and when combined with 0.4g/kg of mannooligosaccharide, trypsin and lipase activities of 28-day old chickens and 49-day old chickens can be obviously improved; the combination of the three components can obviously improve the activity of 28-day-old duodenal amylase of chicks, and the combination effect of 2g/kg of medlar residual fruit powder and 0.4g/kg of mannooligosaccharide is the best.
2G/kg of medlar residual fruit powder and 2g/kg of medlar residual fruit powder are added into daily ration, and are respectively combined with 0.4g/kg of mannooligosaccharide, so that the jejunum villus height of 28-day-old chicks can be obviously increased; 1g/kg of medlar residual fruit powder is added, and the combination of the medlar residual fruit powder and 0.4g/kg of mannooligosaccharide can obviously improve jejunum villus height of 49-day-old chicks; the combination of 2g/kg and 1g/kg of medlar residual fruit powder and 0.4g/kg of mannooligosaccharide can obviously improve the villus height and the villus-to-crypto ratio of 28-day-old and 49-day-old ileum of chicks, as shown in tables 3, 4 and 5.
TABLE 3 influence of defective Lycium barbarum and mannooligosaccharide on the morphological structure of the duodenum of chicks
Note that: the same lower case letters of the shoulder marks are compared with each other, two upper case letters indicate that the difference is extremely remarkable (P < 0.01), and one upper case letter indicates that the difference is remarkable (P < 0.05).
TABLE 4 Effect of Lycium barbarum and mannooligosaccharide on the morphology and Structure of the jejunum of chicks
Note that: the same lower case letters of the shoulder marks are compared with each other, two upper case letters indicate that the difference is extremely remarkable (P < 0.01), and one upper case letter indicates that the difference is remarkable (P < 0.05).
TABLE 5 Effect of Lycium barbarum and mannooligosaccharide on ileum morphology in chicks
Note that: the same lower case letters of the shoulder marks are compared with each other, two upper case letters indicate that the difference is extremely remarkable (P < 0.01), and one upper case letter indicates that the difference is remarkable (P < 0.05).
It is proved that when 2g/kg and 1g/kg of medlar residual fruit powder and 0.4g/kg of medlar residual fruit powder are added into daily ration, the growth performance of chicks can be improved and the intestinal digestion function can be enhanced.
Test example 3: determination of chick intestinal mucosa barrier function
The above example 1 group feeding protocol was used to collect the duodenum, jejunum, and ileum of chicks at 28 and 49 days of age, respectively, and determine their relative amounts of barrier-related Occlutin, ZO-1, and MUC2 mRNA.
FIGS. 4 to 9 are graphs showing the effect of matrimony vine and mannooligosaccharide on the relative expression amounts of chicken small intestine Occludin and ZO-1mRNA, notes: * Indicating significant differences (P < 0.05), indicating very significant differences (P < 0.01).
Fig. 10 to 12 effect of matrimony vine and mannooligosaccharide on relative expression amount of chick intestinal MUC2 mRNA, note: * Indicating significant differences (P < 0.05), indicating very significant differences (P < 0.01).
From FIGS. 4 to 12, it is known that the combination of 2g/kg of the fructus Lycii residue fruit powder and 0.4g/kg of the mannooligosaccharide can increase the relative expression levels of jejunum Occludin and ZO-1mRNA of chicks at 28 days old, up-regulate the relative expression levels of intestinal Occludin and MUC2mRNA, up-regulate the relative expression levels of ileum Occludin at 49 days old, ZO-1 and MUC2mRNA and the relative expression level of MUC2mRNA of duodenum; the combination of 1g/kg of the medlar residual fruit powder and 0.4g/kg of the mannooligosaccharide can improve the relative expression quantity of the duodenal ZO-1 and jejunum MUC2mRNA of the chicks at 28 days old, and the combination of 0.5g/kg of the medlar residual fruit powder and 0.4g/kg of the mannooligosaccharide can improve the relative expression quantity of the duodenal ZO-1 and ileum ZO-1mRNA of the chicks at 49 days old.
Test example 4: determination of the pH of the cecal content and the intestinal flora of the chicks
The above example 1 group feeding protocol was used to collect cecum from chicks at 28 and 49 days of age, respectively, and the pH of the intestinal contents was measured with a pH meter, and the numbers of escherichia coli and lactobacillus were counted by plate counting.
The results are shown in Table 6, and it is clear that the combination of three doses of fructus Lycii residual fruit and 0.4g/kg of mannooligosaccharide can reduce the pH of 7-49 day-old cecum content of chicks, and the combination of 2g/kg of fructus Lycii residual fruit powder and 0.4g/kg of mannooligosaccharide has the best effect. TABLE 6 influence of defective Lycium barbarum and mannooligosaccharide on the pH of the cecum contents of chickens
Grouping 28 Days old 49 Days old
CON 6.77±0.09a 7.22±0.04a
LBH 6.45±0.05e 7.17±0.01AAb
LBM 6.55±0.12b 7.15±0.02AAb
LBL 6.77±0.08b 7.20±0.01b
LBH+ACT 6.25±0.06AABBD 7.02±0.03AABBDEE
LBM+ACT 6.22±0.06AABBE 7.06±0.03AABB
LBL+ACT 6.21±0.04AABBE 7.07±0.03AABBd
ACT 6.47±0.37AA 7.09±0.02AAe
Note that: the same lower case letters of the shoulder marks are compared with each other, two uppercase letters are extremely obvious in difference (P < 0.01), and one uppercase letter is obvious in difference (P < 0.05).
Fig. 13 to 14 are graphs showing the effects of the defective fruits of matrimony vine and mannooligosaccharides on the numbers of E.coli and Lactobacillus in chickens. And (3) injection: * Indicating significant differences (P < 0.05), indicating very significant differences (P < 0.01).
From FIGS. 13 to 14, it is understood that the combination of 2g/kg and 1g/kg of residual fruit powder of Lycium barbarum with 0.4g/kg of mannooligosaccharide can increase the number of Lactobacillus cecum in 28-day-old chicks; the daily ration is added with the residual fruit powder of the medlar and the combination of the residual fruit powder and 0.4g/kg of mannooligosaccharide, so that the quantity of lactobacillus in the cecum content of the 49-day-old chicks can be increased, and the combination effect of 2g/kg and 0.4g/kg of mannooligosaccharide is the best.
In the whole, when 2g/kg and 1g/kg of medlar residual fruit powder are added into daily ration and are respectively combined with 0.4g/kg of mannooligosaccharide, the intestinal mucosa barrier of the chick can be enhanced.
As can be seen from a combination of the above examples: when 2g/kg of medlar residue fruit powder and 0.4g/kg of mannooligosaccharide are added into daily ration of the egg chicks for combined use, the growth performance of the chicks can be improved by improving average daily gain of the chicks and reducing the feed-weight ratio; the intestinal tract digestive enzyme activity is improved, so that the small intestinal villus height and the villus cryptoratio are improved, and the digestion function of the chicks is enhanced; the intestinal barrier function is enhanced by up-regulating the relative expression levels of intestinal tissue-tight junction protein ZO-1, mucin MUC2, and atresia Occludin mRNA, and the intestinal health is regulated by lowering the cecum pH and increasing the number of Lactobacillus in the cecum contents.
Large group test: based on the above examples, the most suitable combination amount of 2g/kg of medlar residual fruit powder and 0.4g/kg of mannooligosaccharide are selected for feeding. Starting feeding at 7 days old, feeding for 10 days every month, and comparing egg yield and egg quality (eggshell color, eggshell strength, egg shape index, yolk color, etc.) of the laying hens before and after feeding.

Claims (4)

1. A pharmaceutical composition for promoting the growth of egg chicks and regulating intestinal functions, which is characterized in that: the composition consists of medlar and mannooligosaccharide, and the dosage of the medlar and the mannooligosaccharide is 1-2: 0.4.
2. A pharmaceutical composition for promoting the growth of egg chicks and regulating intestinal function according to claim 1, wherein: the composition consists of 2g medlar and 0.4 g mannooligosaccharide.
3. A pharmaceutical composition for promoting the growth of egg chickens and regulating intestinal function according to claim 1 or 2, wherein: the medlar is medlar powder.
4. Use of the pharmaceutical composition of claim 1 for the manufacture of a medicament for promoting growth of an egg chicken and regulating intestinal function.
CN202310713063.0A 2023-06-16 2023-06-16 Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions Active CN116549534B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310713063.0A CN116549534B (en) 2023-06-16 2023-06-16 Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310713063.0A CN116549534B (en) 2023-06-16 2023-06-16 Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions

Publications (2)

Publication Number Publication Date
CN116549534A CN116549534A (en) 2023-08-08
CN116549534B true CN116549534B (en) 2024-04-19

Family

ID=87486239

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310713063.0A Active CN116549534B (en) 2023-06-16 2023-06-16 Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions

Country Status (1)

Country Link
CN (1) CN116549534B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102987107A (en) * 2012-09-29 2013-03-27 凤台县瑞普农业发展有限公司 Chick feed

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102987107A (en) * 2012-09-29 2013-03-27 凤台县瑞普农业发展有限公司 Chick feed

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Effects of mannan-oligosaccharide supplementation on gut health, immunity, and production performance of broilers.;Asif M;Brazilian journal of biology;20220101;第84卷;e250132-e250132 *
Goloba kusi (Hornstedtia scottiana [F. Muell.] K. Schum.) fruit as a feed additive to improve the histological structures and growth performance of broiler;Blatama D等人;Veterinary world;20230228;第16卷(第2期);329-340 *

Also Published As

Publication number Publication date
CN116549534A (en) 2023-08-08

Similar Documents

Publication Publication Date Title
CN101554206B (en) Composite plant feed additive
CN102894210B (en) Anti-stress Chinese herbal medicine composite feedstuff additive specially used for penaeus vannamei
WO2015070470A1 (en) Complex carbohydrate formulation for fodder, fodder comprising same, and application
CN103431198A (en) Poultry feed additive and poultry feed
CN105341363A (en) Novel compound feed additive for livestock
CN102078522A (en) Chinese medicine composition for treating enterovirus syndrome in chicken
CN114698742A (en) Piglet feed containing micro-ecological traditional Chinese medicine preparation
CN1328971C (en) Growth promoter of green natural plant
CN111357885A (en) Complete feed and premix for promoting body shape and skeleton development of laying chicks and preparation method thereof
CN101715893B (en) Pure natural piglet immunological enhancement feed additive and application thereof
CN105454712A (en) Silkie feed composition
CN116549534B (en) Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions
CN110179005A (en) Improve the probiotics and measuring method of squab growth performance
CN101595945A (en) A kind of feed addictive that promotes production, strengthens the animal disease resistant ability
CN101564084A (en) Decayed tooth preventing feed additive for improving animal immunizing power
CN107494957A (en) A kind of weanling pig natural health plant compound additive
CN111264460A (en) Selenium-rich laying hen breeding method
CN111149919A (en) Glycerol butyrate compound for poultry as well as preparation method and application thereof
CN110755604A (en) Pharmaceutical composition for preventing and treating poultry adenofibromyositis and application thereof
CN110025774B (en) Ointment for preventing and treating newborn piglet diarrhea and production method thereof
CN107594169A (en) A kind of anti diar rhea pre-mixing agent for reducing Jejunum of Piglets campylobacter and preparation method and application
CN1032897A (en) Have cure the disease, the novel fodder of immunity, many effects such as fatten
CN113974010A (en) Feed additive for weaning of bred animals and use method
Maina et al. Effects of Supplementing Different Levels of Stinging Nettle Leaf Meal on the Growth Performance of Starter Broilers
CN117814363A (en) Plant feed additive and application method thereof in yellow-feather broiler feed

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant